244 related articles for article (PubMed ID: 23171075)
1. Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1.
Rothan HA; Han HC; Ramasamy TS; Othman S; Rahman NA; Yusof R
BMC Infect Dis; 2012 Nov; 12():314. PubMed ID: 23171075
[TBL] [Abstract][Full Text] [Related]
2. Protegrin-1 inhibits dengue NS2B-NS3 serine protease and viral replication in MK2 cells.
Rothan HA; Abdulrahman AY; Sasikumer PG; Othman S; Rahman NA; Yusof R
J Biomed Biotechnol; 2012; 2012():251482. PubMed ID: 23093838
[TBL] [Abstract][Full Text] [Related]
3. Antiviral cationic peptides as a strategy for innovation in global health therapeutics for dengue virus: high yield production of the biologically active recombinant plectasin peptide.
Rothan HA; Mohamed Z; Suhaeb AM; Rahman NA; Yusof R
OMICS; 2013 Nov; 17(11):560-7. PubMed ID: 24044366
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous uncoupled expression and purification of the Dengue virus NS3 protease and NS2B co-factor domain.
Shannon AE; Chappell KJ; Stoermer MJ; Chow SY; Kok WM; Fairlie DP; Young PR
Protein Expr Purif; 2016 Mar; 119():124-9. PubMed ID: 26647367
[TBL] [Abstract][Full Text] [Related]
5. Use of parallel validation high-throughput screens to reduce false positives and identify novel dengue NS2B-NS3 protease inhibitors.
Tomlinson SM; Watowich SJ
Antiviral Res; 2012 Feb; 93(2):245-252. PubMed ID: 22193283
[TBL] [Abstract][Full Text] [Related]
6. Mechanism through Which Retrocyclin Targets Flavivirus Multiplication.
Jia X; Guo J; Yuan W; Sun L; Liu Y; Zhou M; Xiao G; Lu W; Garzino-Demo A; Wang W
J Virol; 2021 Jul; 95(15):e0056021. PubMed ID: 33980602
[TBL] [Abstract][Full Text] [Related]
7. Fusion of protegrin-1 and plectasin to MAP30 shows significant inhibition activity against dengue virus replication.
Rothan HA; Bahrani H; Mohamed Z; Abd Rahman N; Yusof R
PLoS One; 2014; 9(4):e94561. PubMed ID: 24722532
[TBL] [Abstract][Full Text] [Related]
8. A straightforward experimental approach to expression, purification, refolding, and enzymatic analysis of recombinant dengue virus NS2B(H)-NS3pro protease.
Junaid M; Angsuthanasombat C; Wikberg JE; Ali N; Katzenmeier G
Biochemistry (Mosc); 2013 Aug; 78(8):920-4. PubMed ID: 24228881
[TBL] [Abstract][Full Text] [Related]
9. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
Cabarcas-Montalvo M; Maldonado-Rojas W; Montes-Grajales D; Bertel-Sevilla A; Wagner-Döbler I; Sztajer H; Reck M; Flechas-Alarcon M; Ocazionez R; Olivero-Verbel J
Eur J Med Chem; 2016 Mar; 110():87-97. PubMed ID: 26807547
[TBL] [Abstract][Full Text] [Related]
10. Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro.
Yusof R; Clum S; Wetzel M; Murthy HM; Padmanabhan R
J Biol Chem; 2000 Apr; 275(14):9963-9. PubMed ID: 10744671
[TBL] [Abstract][Full Text] [Related]
11. Policresulen, a novel NS2B/NS3 protease inhibitor, effectively inhibits the replication of DENV2 virus in BHK-21 cells.
Wu DW; Mao F; Ye Y; Li J; Xu CL; Luo XM; Chen J; Shen X
Acta Pharmacol Sin; 2015 Sep; 36(9):1126-36. PubMed ID: 26279156
[TBL] [Abstract][Full Text] [Related]
12. Novel dengue virus-specific NS2B/NS3 protease inhibitor, BP2109, discovered by a high-throughput screening assay.
Yang CC; Hsieh YC; Lee SJ; Wu SH; Liao CL; Tsao CH; Chao YS; Chern JH; Wu CP; Yueh A
Antimicrob Agents Chemother; 2011 Jan; 55(1):229-38. PubMed ID: 20937790
[TBL] [Abstract][Full Text] [Related]
13. Study the antiviral activity of some derivatives of tetracycline and non-steroid anti inflammatory drugs towards dengue virus.
Rothan HA; Buckle MJ; Ammar YA; Mohammadjavad P; Shatrah O; Noorsaadah AR; Rohana Y
Trop Biomed; 2013 Dec; 30(4):681-90. PubMed ID: 24522138
[TBL] [Abstract][Full Text] [Related]
14. In vitro antiviral activity of spirotetronate compounds against dengue virus serotype 2.
Euanorasetr J; Intra B; Thunmrongsiri N; Limthongkul J; Ubol S; Anuegoonpipat A; Kurosu T; Ikuta K; Nihira T; Panbangred W
J Gen Appl Microbiol; 2019 Sep; 65(4):197-203. PubMed ID: 30814437
[TBL] [Abstract][Full Text] [Related]
15. NMR analysis of a novel enzymatically active unlinked dengue NS2B-NS3 protease complex.
Kim YM; Gayen S; Kang C; Joy J; Huang Q; Chen AS; Wee JL; Ang MJ; Lim HA; Hung AW; Li R; Noble CG; Lee le T; Yip A; Wang QY; Chia CS; Hill J; Shi PY; Keller TH
J Biol Chem; 2013 May; 288(18):12891-900. PubMed ID: 23511634
[TBL] [Abstract][Full Text] [Related]
16. A quinoline compound inhibits the replication of dengue virus serotypes 1-4 in Vero cells.
Beesetti H; Tyagi P; Medapi B; Krishna VS; Sriram D; Khanna N; Swaminathan S
Antivir Ther; 2018; 23(5):385-394. PubMed ID: 29583121
[TBL] [Abstract][Full Text] [Related]
17. Synthetic peptide optimization improves the inhibition of dengue NS2B-NS3 protease and dengue replication in vitro.
Abdulrahman AY; Rothan HA; Khazali AS; Teoh TC; Daher AM; Yusof R
Acta Virol; 2019; 63(3):278-285. PubMed ID: 31507193
[TBL] [Abstract][Full Text] [Related]
18. An Antiviral Peptide from
Ji M; Zhu T; Xing M; Luan N; Mwangi J; Yan X; Mo G; Rong M; Li B; Lai R; Jin L
Toxins (Basel); 2019 Oct; 11(10):. PubMed ID: 31658707
[TBL] [Abstract][Full Text] [Related]
19. Binding mode of the activity-modulating C-terminal segment of NS2B to NS3 in the dengue virus NS2B-NS3 protease.
de la Cruz L; Chen WN; Graham B; Otting G
FEBS J; 2014 Mar; 281(6):1517-33. PubMed ID: 24472363
[TBL] [Abstract][Full Text] [Related]
20. Exploring the therapeutic potential of DV-B-120 as an inhibitor of dengue virus infection.
Huang Y-J; Cheng T-L; Wang Y-T; Chen C-S; Leu Y-L; Chang C-S; Ho C-H; Chao S-W; Li C-T; Chuang C-H
J Virol; 2024 Apr; 98(4):e0125823. PubMed ID: 38546211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]